Tags:AgriTechBioTechCoffeeCommerceEquipmentIT
Tropic Biosciences is a UK-based biotechnology company focused on utilising advanced plant breeding and gene editing technologies to develop high-performing commercial tropical crops, namely coffee and bananas. It employs 17 industry-leading professionals and is headquartered in Norwich’s renowned John Innes Centre where it has access to cutting-edge equipment and a highly qualified workforce. The company was founded in 2016 by a team of highly experienced entrepreneurs and researchers including Gilad Gershon, an experienced AgriTech private equity investor and entrepreneur; and Dr. Eyal Maori, scientific co-founder of Beelogics, which was acquired by Monsanto in 2013; and Dr Ofir Meir, former Director of R&D in the Crop Protection Division at Evogene. www.tropicbiosciences.com
Total raised: $10M

Investors 1

DateNameWebsite
16.04.2021Five Seaso...fiveseason...

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
13.06.2018Series A$10M-finsmes.co...

Mentions in press and media 1

DateTitleDescriptionCategoryAuthorSource
13.06.2018Tropic Bio...Tropic Biosciences, a Norwich,...UK-finsmes.co...